Independent Research advice for BB Biotech
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| April 20, 2015 | Independent Research | BB Biotech | Sell | 255.00 CHF | 79.76 % |
Advice details
Frankfurt - Op 20 Apr 2015 herhalen de analisten van Independent Research hun verkoopadvies voor BB Biotech (ISIN: CH0038389992 / Mnemo: BBZ). Het 12-maands koersdoel wordt opwaarts bijgesteld van 210.0 CHF naar 255.0 CHF.
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2025 ValueSpectrum. All Rights Reserved
Developed and maintained by 